Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1 Lupus Erythematosus, Systemic 1 Infections 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 4 gamma-Globulins 3 Ciprofloxacin 3 Immunoglobulins, Intravenous 2 Amoxicillin-Potassium Clavulanate Combination 2 talquetamab 1 plerixafor 1 idecabtagene vicleucel 1 anifrolumab 1 Wearable Electronic Devices 1 Vital Signs 1 Procalcitonin 1 Plastic Surgery Procedures 1 Immunoglobulins 1 Fish Oils 1 Ethanol 1 Enteral Nutrition 1 Dietary Supplements 1 Cystectomy 1 Control Groups 1 Clavulanic Acid 1 Amoxicillin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Infections × anifrolumab × Clear all

NCT07000110 2026-05-20

SIMA

AstraZeneca

Infections, Lupus Erythematosus, Systemic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡